Results:
1-21
|
Results: 21
Authors:
Sakamoto, H
Mashima, T
Sato, S
Hashimoto, Y
Yamori, T
Tsuruo, T
Citation: H. Sakamoto et al., Selective activation of apoptosis program by S-p-bromobenzylglutathione cyclopentyl diester in glyoxalase I-overexpressing human lung cancer cells, CLIN CANC R, 7(8), 2001, pp. 2513-2518
Authors:
Fukushima, S
Takeuchi, Y
Kishimoto, S
Yamashita, S
Uetsuki, K
Shirakawa, S
Suzuki, M
Furuta, K
Noyori, R
Sasaki, H
Kikuchi, Y
Kita, T
Yamori, T
Sawada, J
Kojima, M
Hazato, A
Kurozumi, S
Fukushima, M
Citation: S. Fukushima et al., Antitumor activity, optimum administration method and pharmacokinetics of 13,14-dihydro-15-deoxy-Delta(7)-prostaglandin A(1) methyl ester (TEI-9826) integrated in lipid microspheres (Lipo TEI-9826), ANTI-CANC D, 12(3), 2001, pp. 221-234
Authors:
Miyata, F
Yoshida, S
Yamori, T
Katoh, T
Citation: F. Miyata et al., An efficient and expeditious synthesis of a novel 5H-naphth[1',2': 5,6][1,4]oxazino[2,3-b]quinoxalin-5-one and its unique inhibitory activity againsta panel of human cancer cell lines, HETEROCYCLE, 54(2), 2001, pp. 619
Authors:
Iwasa, K
Moriyasu, M
Yamori, T
Turuo, T
Lee, DU
Wiegrebe, W
Citation: K. Iwasa et al., In vitro cytotoxicity of the protoberberine-type alkaloids, J NAT PROD, 64(7), 2001, pp. 896-898
Authors:
Komatsu, Y
Tomizaki, K
Tsukamoto, M
Kato, T
Nishino, NK
Sato, SG
Yamori, T
Tsuruo, T
Furumai, R
Yoshida, M
Horinouchi, S
Hayashi, H
Citation: Y. Komatsu et al., Cyclic hydroxamic-acid-containing peptide 31, a potent synthetic histone deacetylase inhibitor with antitumor activity, CANCER RES, 61(11), 2001, pp. 4459-4466
Authors:
Saji, H
Koike, M
Yamori, T
Saji, S
Seiki, M
Matsushima, K
Toi, M
Citation: H. Saji et al., Significant correlation of monocyte chemoattractant protein-1 expression with neovascularization and progression of breast carcinoma, CANCER, 92(5), 2001, pp. 1085-1091
Authors:
Omoto, Y
Kobayashi, Y
Nishida, K
Tsuchiya, E
Eguchi, H
Nakagawa, K
Ishikawa, Y
Yamori, T
Iwase, H
Fujii, Y
Warner, M
Gustafsson, JA
Hayashi, S
Citation: Y. Omoto et al., Expression, function, and clinical implications of the estrogen receptor beta in human lung cancers, BIOC BIOP R, 285(2), 2001, pp. 340-347
Authors:
Dan, S
Yamori, T
Citation: S. Dan et T. Yamori, Repression of cyclin B1 expression after treatment with adriamycin, but not cisplatin in human lung cancer A549 cells, BIOC BIOP R, 280(3), 2001, pp. 861-867
Authors:
Su, W
Ito, T
Oyama, T
Kitagawa, T
Yamori, T
Fujiwara, H
Matsuda, H
Citation: W. Su et al., The direct effect of IL-12 on tumor cells: IL-12 acts directly on tumor cells to activate NF-kappa B and enhance IFN-gamma-mediated STAT1 phosphorylation, BIOC BIOP R, 280(2), 2001, pp. 503-512
Authors:
Oyama, T
Miyoshi, Y
Koyama, K
Nakagawa, H
Yamori, T
Ito, T
Matsuda, H
Arakawa, H
Nakamura, Y
Citation: T. Oyama et al., Isolation of a novel gene on 8p21.3-22 whose expression is reduced significantly in human colorectal cancers with liver metastasis, GENE CHROM, 29(1), 2000, pp. 9-15
Authors:
Egawa, K
Yamori, T
Nosaka, C
Kunimoto, S
Takeuchi, T
Nose, K
Citation: K. Egawa et al., Deoxynybomycin is a selective anti-tumor agent inducing apoptosis and inhibiting topoisomerase I, BIOL PHAR B, 23(9), 2000, pp. 1036-1040
Authors:
Akiyama, N
Hijikata, M
Kobayashi, A
Yamori, T
Tsuruo, T
Natori, S
Citation: N. Akiyama et al., Anti-tumor effect of N-beta-alanyl-5-S-glutathionyl-dihydroxyphenylalanine(5-S-GAD), a novel anti-bacterial substance from an insect, ANTICANC R, 20(1A), 2000, pp. 357-362
Authors:
Kuroda, M
Mimaki, Y
Sashida, Y
Yamori, T
Tsuruo, T
Citation: M. Kuroda et al., Galtonioside A, a novel cytotoxic cholestane glycoside from Galtonia candicans, TETRAHEDR L, 41(2), 2000, pp. 251-255
Authors:
Hosokawa, N
Iinuma, H
Takeuchi, T
Sato, S
Yamori, T
Tsuchiya, KS
Hori, M
Citation: N. Hosokawa et al., Anticancer and some biological activities of thiazinotrienomycin B, J ANTIBIOT, 53(3), 2000, pp. 306-308
Authors:
Mimaki, Y
Kuroda, M
Sashida, Y
Yamori, T
Tsuruo, T
Citation: Y. Mimaki et al., Candicanoside A, a novel cytotoxic rearranged cholestane glycoside from Galtonia candicans, HELV CHIM A, 83(10), 2000, pp. 2698-2704
Authors:
Hoshino, R
Chatani, Y
Yamori, T
Tsuruo, T
Oka, H
Yoshida, O
Shimada, Y
Ari-i, S
Wada, H
Fujimoto, J
Kohno, M
Citation: R. Hoshino et al., Constitutive activation of the 41-/43-kDa mitogen-activated protein kinasesignaling pathway in human tumors, ONCOGENE, 18(3), 1999, pp. 813-822
Authors:
Hirai, KI
Koyama, J
Pan, JH
Simamura, E
Shimada, H
Yamori, T
Sato, S
Tagahara, K
Tsuruo, T
Citation: Ki. Hirai et al., Furanonaphthoquinone analogs possessing preferential antitumor activity compared to normal cells, CANCER DET, 23(6), 1999, pp. 539-550
Authors:
Iwasa, K
Nishiyama, Y
Ichimaru, M
Moriyasu, M
Kim, HS
Wataya, Y
Yamori, T
Takashi, T
Lee, DU
Citation: K. Iwasa et al., Structure-activity relationships of quaternary protoberberine alkaloids having an antimalarial activity, EUR J MED C, 34(12), 1999, pp. 1077-1083
Authors:
Naasani, I
Seimiya, H
Yamori, T
Tsuruo, T
Citation: I. Naasani et al., FJ5002: A potent telomerase inhibitor identified by exploiting the disease-oriented screening program with COMPARE analysis, CANCER RES, 59(16), 1999, pp. 4004-4011
Authors:
Yamori, T
Matsunaga, A
Sato, S
Yamazaki, K
Komi, A
Ishizu, K
Mita, I
Edatsugi, H
Matsuba, Y
Takezawa, K
Nakanishi, O
Kohno, H
Nakajima, Y
Komatsu, H
Andoh, T
Tsuruo, T
Citation: T. Yamori et al., Potent antitumor activity of MS-247, a novel DNA minor groove binder, evaluated by an in vitro and in vivo human cancer cell line panel, CANCER RES, 59(16), 1999, pp. 4042-4049
Authors:
Chen, ZH
Naito, M
Hori, S
Mashima, T
Yamori, T
Tsuruo, T
Citation: Zh. Chen et al., A human IAP-family gene, Apollon, expressed in human brain cancer cells, BIOC BIOP R, 264(3), 1999, pp. 847-854
Risultati:
1-21
|